Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION
Report ID | 174102 |
Drug Identification Number | 02423227 |
Brand name | AMIODARONE HYDROCHLORIDE FOR INJECTION |
Common or Proper name | Amiodarone Hydrochloride for Injection, USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 3 mL vials |
ATC code | C01BD |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-11-09 |
Estimated end date | 2023-02-28 |
Actual end date | 2023-01-08 |
Shortage status | Resolved |
Updated date | 2023-01-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-01-10 | French | Compare |
v6 | 2023-01-10 | English | Compare |
v5 | 2022-12-09 | French | Compare |
v4 | 2022-12-09 | English | Compare |
v3 | 2022-11-10 | English | Compare |
v2 | 2022-11-09 | French | Compare |
v1 | 2022-11-09 | English | Compare |
Showing 1 to 7 of 7